Recalling firm
Dr. Reddy's Laboratories, Inc.
Product type
Drug
Status
Terminated
Report date
2024-01-17
Distribution
US Nationwide.
Firm state
NJ
Product quantity
8,280 bottles
Initiated by
Voluntary: Firm initiated
Reason for recall
Presence of Foreign Tablets/Capsules: One 0.5 mg Tacrolimus capsule found in a bottle of 1 mg Tacrolimus capsules.
Product description
Tacrolimus Capsules, USP 1mg, 100-Count Bottles, Rx Only, Manufactured by: Dr. Reddy's Laboratories Limited, Bachupally, 500 090, INDIA, NDC 55111-526-01
Code / lot info
Lot# C2307275; Exp. January 2026
Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.